Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation (NEW-AF)

NCT03702582 PHASE3 COMPLETED

This prospective, randomized, active-controlled, parallel arm study compares the safety and financial benefits of arterial thromboembolism prophylaxis with Warfarin vs. Rivaroxaban (A novel oral anticoagulant) in patients with new onset atrial fibrillation after sternotomy for cardiac operations.

Details

Lead sponsor	Massachusetts General Hospital
Phase	PHASE3
Status	COMPLETED
Enrolment	100
Start date	Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Oct 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Atrial Fibrillation
• Stroke
• Bleeding

Interventions

• Rivaroxaban
• Warfarin

Countries

United States